HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MicroRNA‑218 inhibits the malignant phenotypes of glioma by modulating the TNC/AKT/AP‑1/TGFβ1 feedback signaling loop.

Abstract
Gliomas are the most malignant and common tumors of the human brain, and the prognosis of glioma patients is extremely poor. MicroRNAs (miRNAs or miRs) play critical roles in different types of cancer by performing post‑transcriptional regulation of gene expression. Although miR‑218 has been demonstrated to be decreased in gliomas, its role in gliomas remains largely unknown. miR‑218 expression was analyzed in gliomas and normal brain tissues (control subjects) using a dataset from The Cancer Genome Atlas. A series of in vitro and in vivo studies were performed to determine the biological roles of miR‑218 in glioma cells. Potential targets of miR‑218 were identified using a dual‑luciferase reporter system. Western blot and dual‑luciferase reporter system experiments were performed to evaluate the regulatory effect of miR‑218 on the tenascin C (TNC)/AKT/activator protein 1 (AP‑1)/transforming growth factor β1 (TGFβ1) pathway. It was demonstrated that miR‑218 was significantly downregulated in gliomas compared with control subjects, and played potent tumor suppressor roles in glioma cells by inhibiting cell proliferation, colony formation, migration, invasion and tumorigenic potential in nude mice, as well as inducing cell cycle arrest and apoptosis. Mechanistically, miR‑218 inhibited malignant phenotypes of glioma cells by binding to the 3'‑untranslated region of its target TNC and subsequently suppressing its expression. As a result, miR‑218 could reduce AKT phosphorylation and subsequently inhibit transcriptional activity of AP‑1 by reducing JNK phosphorylation, downregulating the expression of TGFβ1, while TGFβ1 was able to, in turn, activate the TNC/AKT/AP‑1 signaling axis. Our data revealed a previously unknown tumor suppressor role of miR‑218 by blocking the TNC/AKT/AP‑1/TGFβ1‑positive feedback loop in glioma.
AuthorsSiwen Dang, Rui Zhang, Sijia Tian, Peng Hou, Gang Li, Meiju Ji
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 48 Issue 5 (11 2021) ISSN: 1791-244X [Electronic] Greece
PMID34558654 (Publication Type: Journal Article)
Chemical References
  • MIRN218 microRNA, human
  • MicroRNAs
  • Tenascin
  • Transcription Factor AP-1
  • Transforming Growth Factor beta1
  • Proto-Oncogene Proteins c-akt
Topics
  • Animals
  • Apoptosis (genetics)
  • Cell Cycle Checkpoints (genetics)
  • Cell Proliferation (genetics)
  • Down-Regulation (genetics)
  • Feedback, Physiological
  • Gene Expression Regulation, Neoplastic
  • Glioma (genetics, pathology)
  • Male
  • Mice
  • MicroRNAs (genetics, metabolism)
  • Phenotype
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Signal Transduction
  • Tenascin (metabolism)
  • Transcription Factor AP-1 (metabolism)
  • Transforming Growth Factor beta1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: